New Study Finds Cannabinoids An Effective Treatment For Multiple Sclerosis

A new study published in this month’s issue of the journal European Neurology, and published online by the U.S. National Institute of Health,stock2 has found that Sativex – a medicinal spray made from the cannabis plant – is an effective and safe treatment option for “moderate to severe multiple sclerosis spasticity (MSS)”.

According to researchers: “Nabiximols (Sativex®), a cannabinoid-based oromucosal spray, is an add-on therapy for patients with moderate to severe multiple sclerosis spasticity (MSS) resistant to other medications. The primary objective was to provide real-life observational data of clinical experience of nabiximols in contrast to formal clinical trials of effectiveness.”

Read moreNew Study Finds Cannabinoids An Effective Treatment For Multiple Sclerosis

Study: Cannabinoids Can Treat Symptoms of Multiple Sclerosis Better Than Pharmaceutical Alternatives

A study published in the journal Expert Review of Neurotherapeutics, and published online by the National Institute of Health, has found promising evidence that cannabinoidsrx can provide a natural treatment for the symptoms of multiple sclerosis.

“In an experimental mouse model of MS-related spasticity, Sativex [a product made entirely from cannabis] dose-dependently improved hind limb flexion/stiffness and a dosage of 10 mg/kg was shown to be as [or more] effective as the most widely established anti-spasticity treatment baclofen (5 mg/kg)”, claims the study.

Read moreStudy: Cannabinoids Can Treat Symptoms of Multiple Sclerosis Better Than Pharmaceutical Alternatives

Switzerland Legalizes Cannabis Medicine

Switzerland has officially become the 23rd nation in the world to approve Sativex for use by those with multiple sclerosis; Sativexsativex is a medical spray made up entirely of cannabis-derived cannabinoids.

“This approval in Switzerland marks yet another regulatory success for Sativex, which is now approved in a total of 23 countries,” stated Justin Gover, Chief Executive Officer of GW Pharmaceuticals, the company behind the product. “We now look forward to working with our partners.. towards this launch so as to enable MS patients in Switzerland to benefit from this important new treatment.”

Read moreSwitzerland Legalizes Cannabis Medicine

New Study: Cannabis Can Treat Multiple Sclerosis By Preventing Inflammation

A new study published by the Journal of Neuroimmune Pharmacology has found that cannabis can treat multiple sclerosis by preventing inflammation in the brain and spinal cord. cannabud

“Inflammation is part of the body’s natural immune response, but in cases like MS it gets out of hand,” says Drs. Ewa Kozela, co-author of the study. “Our study looks at how compounds isolated from marijuana can be used to regulate inflammation to protect the nervous system and its functions.”

Read moreNew Study: Cannabis Can Treat Multiple Sclerosis By Preventing Inflammation

University Lecturer Receives Prestigious Neuroscience Award for Work With Cannabinoids

Dr. Eric Downer, an investigator and lecturer at the Department of Anatomy & Neuroscience at the University College Cork in Ireland, has become the newest recipient of the prestigious Neuroscience Ireland Early Career neuroscienceInvestigator Award for his pioneering work using cannabinoids to treat multiple sclerosis.

‘It is an important time in the field of cannabinoid-based scientific research, particularly in terms of cannabis-based therapies associated with MS’, says Dr Downer, “My research has indicated that MS patient cells, and not cells isolated from healthy individuals, respond to cannabinoid therapy in terms of boosting protective intracellular signaling events.”

Read moreUniversity Lecturer Receives Prestigious Neuroscience Award for Work With Cannabinoids

Cannabis Treats Primary Symptom of Multiple Sclerosis, Says Double-Blind, Placebo-Controlled Study

A study published last year by the Journal of Neurology, Neurosurgey and Psychiatry, as well as the National Institute of Health, found that cannabis can treat the primary symptom of multiple sclerosis, muscle stiffness.saved11 The study followed the gold standard of scientific research, being double-blind, placebo-controlled and used human subjects.

According to the study’s official objective; “Here we report the results of the Multiple Sclerosis and Extract of Cannabis (MUSEC) study that aimed to substantiate the patient based findings of previous studies.”

Read moreCannabis Treats Primary Symptom of Multiple Sclerosis, Says Double-Blind, Placebo-Controlled Study

New Study: Cannabis Can Reduce the Pain Associated With Rare Form of Multiple Sclerosis

A new study published in the science journal PLOS One has found that activation of the body’s cannabinoid receptors – something which cannabis does naturallysaved1 – is directly linked to a reduction in the pain associated with Devic’s syndrome, a rare form of multiple sclerosis.

The study, which was funded in part by the German Research Foundation, the German Federal Ministry of Education and Research and the German Research Network on Neuropathic Pain, found that; “Consequently, increasing plasma levels of 2-AG [a cannabinoid receptor] mitigate mechanical pain sensitivity, while an absence of 2-AG increase leaves these NMO [neuromyelitis optica] patients with full-blown hyperalgesia.”

Read moreNew Study: Cannabis Can Reduce the Pain Associated With Rare Form of Multiple Sclerosis